Time To Crack Down On The Knock-Off Weight-Loss Drug Trade

Modern,Medical,Research,Laboratory,With,Microscope,And,Test,Tubes,With

The booming trade in illicit GLP-1s deserves a swift crackdown. Until that happens, too many Americans will continue to risk their health on potentially dangerous weight-loss medications.

Wegovy, Zepbound, and other GLP-1 agonists have given Americans an extraordinary new tool for losing weight and improving their health. But they’ve also given rise to a dangerous new public health threat—counterfeit medicines.

In a rush to capitalize on the popularity of these drugs, a number of third-party telehealth firms and online pharmacies have been selling unapproved “compounded” versions—many of which are made with potentially harmful ingredients from China.

The result is that countless Americans who believe they are buying safe, tested weight-loss therapies are in fact putting their health at risk. It’s time for lawmakers and regulators to do something about it.

Read the op-ed here. 

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top